REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX | NASDAQ
Chart Builder DCF Calculator
$7.88
-$0.15 (-1.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.88
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$415.13M
Enterprise Value
$370.81M
Beta
0.93
Average Volume
1.92M
Shares Outstanding (Diluted)
53.02M
Shares Change YoY
2.98%
Institutional Ownership
81.24%
Exchange
NASDAQ
ISIN
US75901B1070

Price Performance

Price Change 1M
-5.0%
Price Change 3M
-20.8%
Price Change 6M
-6.9%
Price Change YTD
-41.9%
Price Change 1Y
-13.0%
Price Change 3Y
-54.0%
Price Change 5Y
-81.4%
1M CAGR (ann.)
-28.8%
1Y CAGR (ann.)
-11.1%
5Y CAGR (ann.)
-24.7%
All-Time CAGR
-11.4%

Valuation

PE Ratio
-2.08
Forward PE
N/A
PEG Ratio
0.05
Forward PEG
0.16
PS Ratio
2.33
Forward PS
1.90
PB Ratio
5.68
P/FCF Ratio
-1.25
P/Adj. FCF Ratio
-1.10
P/OCF Ratio
-1.69
EV/Sales
2.13
EV/EBIT
-2.40
EV/EBITDA
-2.67
EV/FCF
-1.13
Earnings Yield
-48.1%
FCF Yield
-80.3%
Adj. FCF Yield
-91.0%

Financial Health

Net Cash
$36.57M
Total Debt
$68.95M
Cash & Short-Term Investments
$105.52M
Total Assets
$386.62M
Current Ratio
2.86
Quick Ratio
2.86
Debt / Equity Ratio
0.96
Debt / EBITDA
-0.50
Debt / FCF
-0.21
OCF / Debt
-4.68
Interest Coverage
-3.91
Altman Z-Score
-3.92
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
54.2%
Operating Profit Margin
-94.1%
EBITDA Margin
-79.7%
Net Profit Margin
-112.6%
FCF Margin
-187.5%
Adj. FCF Margin
-212.5%
SBC / Revenue
20.1%
SBC Impact (per share)
-13.4%

Returns

Return on Assets
-50.8%
Return on Equity
-220.1%
Return on Invested Capital
-52.7%
Return on Capital Employed
-54.0%
Return on Tangible Assets
-50.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
21.6%
Revenue CAGR 5Y
1.6%
Revenue CAGR 10Y
35.5%
EPS CAGR 3Y
17.8%
EPS CAGR 5Y
-24.6%
EPS CAGR 10Y
-16.5%
FCF CAGR 3Y
-32.4%
FCF CAGR 5Y
-49.9%
FCF CAGR 10Y
-23.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
20
EPS Growth Next 3Y
36.9%
Revenue Growth Next 3Y
48.6%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$1.21
EPS Growth Est (next Q)
0.7%
Revenue Est (next Q)
$15.86M
Revenue Growth Est (next Q)
-46.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$19.60
Price Target Upside
148.7%

Cash Flow

Operating Cash Flow
$-322.86M
Free Cash Flow
$-327.09M
Adj. Free Cash Flow
$-370.75M
FCF Per Share
-$4.73
OCF Per Share
-$4.67
OCF/S Ratio
-141.4%

Income Statement

Revenue
$174.48M
Gross Profit
$94.61M
Operating Income
$-164.15M
EBITDA
$-139.12M
Net Income
$-196.43M
EPS (Diluted)
-$3.79
Revenue / Employee
$470.3K
Profit / Employee
$-529.47K
Employees
371

© 2026 bestshares.com. All rights reserved.